View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Mirvetuximab Soravtansin 6 / Bevacizumab 15, Ovarian Carcinoma
Protocol-ID: 3246 V1.0 (Mini), MIRVSO6/BEVA15, Ovarian CancerIndication(s)
- Ovarian Tumor; ICD-10 C56
Folate receptor alpha positive
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 20.09.2026